Results 41 to 50 of about 88,182,083 (298)

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Harm Reduction Journal, 2021
Background Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Anna Beth Parlier-Ahmad, Mishka Terplan, Dace S. Svikis, Laura Ellis, Caitlin E. Martin   +4 more
doaj   +1 more source

Review of medication-assisted treatment for opioid use disorder

Journal of Osteopathic Medicine, 2022
Abstract Context The American opioid epidemic has necessitated the search for safe and effective means of treatment for opioid use disorder (OUD). Medication-assisted treatment (MAT) encompasses select medications that are proven effective treatments for OUD.
Nessreen, Ghanem, Devin, Dromgoole, Ahmad, Hussein, Richard T, Jermyn   +3 more
openaire   +2 more sources

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

Hepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper   +4 more
wiley   +1 more source

Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions

, 2017
The prevalence of risky opioid use, opioid use disorder, and related harms continue to rise among youth (adolescents and young adults age 15-25) in North America.
Jan Klimas, Wood, Evan, Derek C. Chang, Evan Wood, Chang, Derek C, Chang, Derek, Fairbairn, Nadia, Nadia Fairbairn, Klimas, Jan, Chang, Derek C.   +9 more
core   +1 more source

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Opioid use Disorder for Prescription Opioid Medications

Global Journal of Addiction & Rehabilitation Medicine, 2017
Why are opioid medications prescribed in large quantities and high frequency when there is little or no proven efficacy for their therapeutic value? Why are opioids the most commonly prescribed medication in the United States for the past decades when the adverse consequences continue to grow and mount?
openaire   +1 more source

Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial

BMC Public Health, 2021
Background A key strategy for mitigating the current opioid epidemic is expanded access to medications for treating opioid use disorder (MOUD). However, interventions developed to expand MOUD access have limited ability to engage opioid users at higher ...
Dennis P. Watson, James A. Swartz, Lisa Robison-Taylor, Mary Ellen Mackesy-Amiti, Kim Erwin, Nicole Gastala, Antonio D. Jimenez, Monte D. Staton, Sarah Messmer   +8 more
doaj   +1 more source

Unlocking the potential of cell‐permeable nanobodies for intracellular applications

FEBS Letters, EarlyView.
This review outlines current strategies for delivery of nanobodies into cells and highlights recent examples of functional applications. By addressing and manipulating intracellular targets, these molecules hold great potential for treating cancer, respiratory diseases and neurological disorders, making this a vibrant area of research in the biomedical
Mariona Gené‐Verdés, Luise Franz, Christian P.R. Hackenberger   +2 more
wiley   +1 more source

COVID‐19: A new barrier to treatment for opioid use disorder in the emergency department

Journal of the American College of Emergency Physicians Open, 2021
Objective Start Treatment and Recover (STAR) is an emergency department (ED) program that expands access to medication for opioid use disorder by identifying patients with opioid use disorder and offering ED‐initiated buprenorphine/naloxone and rapid ...
Warren Grunvald, Ramsey Herrington, Roz King, Miles Lamberson, Scott Mackey, Sanchit Maruti, Richard Rawson, Daniel Wolfson   +7 more
doaj   +1 more source

Conceptual model for effects of three methods of medication for opioid use disorder (MOUD) induction on long-term maintenance treatment.

, 2023
Conceptual model for effects of three methods of medication for opioid use disorder (MOUD) induction on long-term maintenance treatment.
Donald E. Nease Jr. (16954513), Maret Felzien (16954522), David Wolff (3506819), Ben Sofie (16954516), Linda Zittleman (16954525), L. Miriam Dickinson (8852369), Cory Lutgen (6868019), Lori Heeren (16954519), Douglas H. Fernald (16954510), John M. Westfall (10955511), Bethany M. Kwan (7921289), Jennifer K. Carroll (13770173)   +11 more
core   +1 more source